Unleashing the Potential: Designing Antibody-Targeted Lipid Nanoparticles for Industrial Applications with CMC Considerations and Clinical Outlook

已完结 10 由 1236544 发布于 2024/6/10 8:08:50

DOI:10.1021/acs.molpharmaceut.3c00735
作者：Sheryl Wang, Hong Wang, Andrew Drabek, Wenwen Sha Smith, Feng Liang and Zhaohua Richard Huang*,
文献类型：期刊论文
补充材料：只需要正文

American Chemical Society (ACS)

Abstract：Antibody-targeted lipid nanoparticles (Ab-LNPs) are rapidly gaining traction as multifaceted platforms in precision medicine, adept at delivering a diverse array of therapeutic agents, inclu

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureNanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact